{
    "nctId": "NCT02065960",
    "briefTitle": "Feasibility Study of Stereotactic Body Radiotherapy for Early Breast Cancer",
    "officialTitle": "Feasibility Study of the Role of Stereotactic Body Radiotherapy for the Treatment of Early Stage Breast Cancer",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Neoplasm",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 32,
    "primaryOutcomeMeasure": "Feasibility",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women age \u2265 70 years;\n* New histological diagnosis of invasive carcinoma of the breast, grade I or II, estrogen and progesterone receptor (ER and PR) positive, HER2 negative on needle biopsy and limited to Stage I (T1 N0 M0) on clinical and radiological assessment with MRI of the breasts and axillary ultrasound;\n* Candidate for breast conserving surgery;\n* Signed study consent form completed prior to study entry.\n\nExclusion Criteria:\n\n* Breast cancer with disease within 5 mm from skin or chest wall;\n* Previous or concomitant invasive malignancies treated within 5 years of study entry;\n* Serious non-malignant disease (cardiovascular, pulmonary, systemic lupus or scleroderma), which would preclude to definitive radiation therapy;\n* Psychiatric disorders, which would preclude from obtaining informed consent\n* Geographic inaccessibility for follow-up",
    "sex": "FEMALE",
    "minimumAge": "70 Years",
    "stdAges": "OLDER_ADULT"
}